Novel Drugs for IPF Improve Lung Function in Mid-Stage Trials
'These are among the two most exciting sets of results we've seen,' researcher says
Source: medpagetoday.com
Stay updated with breaking news from Randy Dotinga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'These are among the two most exciting sets of results we've seen,' researcher says
Millions in the U.S. may be reclassified, changing work eligibility, disability compensation
An open-label extension trial of pamrevlumab was cancelled due to these results
While they don't seem to cause any harm, the supplements failed to improve symptoms
Report suggests several tools are inadequate, but app developers question the findings